Trials / Completed
CompletedNCT00627523
Genotropin Treatment In Very Young Children Born Small For Gestational Age
A Two Year Multicentre, Randomized Two Arm Study Of Genotropin Treatment In Very Young Children Born Small For Gestational Age: Early Growth And Neurodevelopment(Egn)
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 43 (actual)
- Sponsor
- Pfizer · Industry
- Sex
- All
- Age
- 19 Months – 29 Months
- Healthy volunteers
- Not accepted
Summary
To demonstrate the effect on height and psychomotor development of Growth Hormone treatment in very young children starting at an age of 2 years.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Genotropin (PN-180,307) Somatropin | Injectable Genotropin |
| DRUG | Control-no treatment | Control-no treatment |
Timeline
- Start date
- 2008-02-01
- Primary completion
- 2013-12-01
- Completion
- 2013-12-01
- First posted
- 2008-03-03
- Last updated
- 2014-11-04
- Results posted
- 2014-09-18
Locations
17 sites across 9 countries: Belgium, Czechia, France, Germany, Italy, Netherlands, Spain, Sweden, Switzerland
Source: ClinicalTrials.gov record NCT00627523. Inclusion in this directory is not an endorsement.